Envista Holdings (NVST) Cash & Equivalents (2019 - 2026)
Envista Holdings (NVST) posted quarterly Cash & Equivalents of $1.1 billion for Q2 2026, up 0.51% year-over-year from $1.1 billion in Q2 2025, and down 10.64% quarter-over-quarter from $1.2 billion in Q4 2025.
Envista Holdings (NVST) Cash & Equivalents (2019 - 2026) Analysis & Trends
Envista Holdings' Cash & Equivalents history runs 8 years deep, the most recent figure standing at $1.1 billion for Q2 2026.
- In Q2 2026, Cash & Equivalents rose 0.51% year-over-year to $1.1 billion; the TTM figure through Apr 2026 stood at $1.1 billion (up 0.51% YoY), while the FY2025 annual figure was $1.2 billion, up 13.34% from the prior year.
- Cash & Equivalents for Q2 2026 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
- The five-year high for Cash & Equivalents was $1.2 billion in Q4 2025, with the low at $523.1 million in Q3 2022.
- The 5-year median for Cash & Equivalents is $991.3 million (2024), against an average of $908.2 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents jumped 144.4% in 2022, then sank 45.73% in 2023.
- Envista Holdings' Cash & Equivalents stood at $606.9 million in 2022, then soared by 54.89% to $940.0 million in 2023, then gained by 13.73% to $1.1 billion in 2024, then rose by 13.34% to $1.2 billion in 2025, then retreated by 10.64% to $1.1 billion in 2026.
- Business Quant data shows NVST's Cash & Equivalents at $1.1 billion in Q2 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 708.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.33 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn | 1.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 1.13 Bn |
| Apr 3, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 26, 2025 | 1.13 Bn |
| Jun 27, 2025 | 1.11 Bn |
| Mar 28, 2025 | 1.08 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 27, 2024 | 991.30 Mn |
| Jun 28, 2024 | 1.04 Bn |
| Mar 29, 2024 | 948.50 Mn |
| Dec 31, 2023 | 940.00 Mn |
| Sep 29, 2023 | 824.20 Mn |
| Jun 30, 2023 | 651.70 Mn |
| Mar 31, 2023 | 585.20 Mn |
| Dec 31, 2022 | 606.90 Mn |
| Sep 30, 2022 | 568.50 Mn |
| Jul 1, 2022 | 523.10 Mn |
| Apr 1, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.07 Bn |
| Oct 1, 2021 | 638.80 Mn |